Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06494514
What this trial is testing

NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Cancer
Du Juan 40
Large-scale testing (Phase 3)Study completedNCT01619111
What this trial is testing

DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCs

Who this might be right for
HER2-negative Metastatic Breast CancerHER2-positive Circulating Tumor Cells
Prof. Wolfgang Janni 105
Large-scale testing (Phase 3)Study completedNCT00256698
What this trial is testing

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

Who this might be right for
Breast Cancer
AstraZeneca 514
Large-scale testing (Phase 3)Active Not RecruitingNCT06746116
What this trial is testing

Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in Spain

Who this might be right for
Advanced or Recurrent Endometrial Cancer
AstraZeneca 45
Large-scale testing (Phase 3)Looking for participantsNCT06817161
What this trial is testing

Benefit of Transcutaneous Auricular Vagus Nerve Stimulation in Improving Quality of Life in First Line Treatment of Ovarian Cancer:

Who this might be right for
Ovarian CarcinomaFirst Line ChemotherapyDigestive System Disorders
Centre Francois Baclesse 116
Testing effectiveness (Phase 2)UnknownNCT05821361
What this trial is testing

HAIC Combined With Cadonilimab and Bevacizumab as First-line Therapy in Unresectable Hepatocellular Carcinoma

Who this might be right for
Unrescetable Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)Looking for participantsNCT05471856
What this trial is testing

Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

Who this might be right for
Solid Tumors
Boehringer Ingelheim 66
Testing effectiveness (Phase 2)UnknownNCT05077839
What this trial is testing

Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC

Who this might be right for
First-line TreatmentAdvanced Colorectal Cancer
Tianjin Medical University Cancer Institute and Hospital 184
Testing effectiveness (Phase 2)WithdrawnNCT07353957
What this trial is testing

Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer - Non Small Cell SquamousLung Cancer - Non Small Cell Non-Squamous
Merus B.V.
Testing effectiveness (Phase 2)Study completedNCT03586999
What this trial is testing

Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas

Who this might be right for
Peripheral T Cell Lymphoma
University of Colorado, Denver 18
Large-scale testing (Phase 3)Active Not RecruitingNCT04923893
What this trial is testing

Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 743
Early research (Phase 1)Looking for participantsNCT07193628
What this trial is testing

B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma

Who this might be right for
Refractory GlioblastomaRecurrent Glioblastoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 14
Large-scale testing (Phase 3)Study completedNCT00455936
What this trial is testing

First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker

Who this might be right for
Lung Cancer
National Cancer Center, Korea 315
Testing effectiveness (Phase 2)UnknownNCT01249521
What this trial is testing

Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Austin Health 40
Not applicableNot Yet RecruitingNCT06935136
What this trial is testing

Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma

Who this might be right for
CAR-T Cell TherapyHigh-risk Large B-cell Lymphoma (LBCL)
Ruijin Hospital 60
Post-approval studies (Phase 4)Study completedNCT00756509
What this trial is testing

Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 34
Not applicableLooking for participantsNCT06751914
What this trial is testing

Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment

Who this might be right for
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University 10
Not applicableStudy completedNCT07408271
What this trial is testing

The Impact of Helicobacter Pylori Eradication on the Vaginal Microecology Change

Who this might be right for
Helicobacter Pylori InfectionHelicobacter Pylori Eradication Antibiotic
Second Affiliated Hospital, Zhejiang University, School of Medicine 83
Large-scale testing (Phase 3)Study completedNCT04410198
What this trial is testing

Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis Participants

Who this might be right for
Anemia Associated With End Stage Renal Disease (ESRD)
Kyntra Bio 203
Large-scale testing (Phase 3)Study completedNCT01910987
What this trial is testing

Study to Evaluate Optimized Retreatment and Prolonged Therapy With Bortezomib

Who this might be right for
Multiple Myeloma
Janssen-Cilag International NV 80
Next Page